Programs, Origins, and Niches of Immunomodulatory Myeloid Cells in Gliomas
T. E. Miller, C. A. K. El Farran, C. P. Couturier, Z. Chen, J. P. D'Antonio, J. Verga, M. A. Villanueva, L. N. G. Castro, Y. E. Tong, T. Al-Saadi, A. N. Chiocca, D. S. Fischer, D. H. Heiland, J. L. Guerriero, K. Petrecca, , B. E. Bernstein
The paper identifies four immunomodulatory programs in glioma-associated myeloid cells using scRNA-seq and shows they are driven by microenvironmental cues and therapies, not cell type or mutation status.
bioRxiv · Oct 24, 2023 · PreprintCancer Biology